(2E)-3-(3-FORMYL-4-HYDROXYPHENYL)PROP-2-ENOIC ACID, 95%, 100mg

4-Amino-3-(tert-butyl)benzonitrile, 97%, 100mg

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 200 ml, 14/23, 2 Unidad(es)

6-Methylsalicylic acid ethyl ester, 95.0%, 10g

4,4,5,5-Tetramethyl-2-(4-((trifluoromethyl)thio)phenyl)-1,3,2-dioxaborolane, 95.0%, 5g

Hexadecanedioic Acid>97.0%(GC)(T)25g

3-(2-Benzothiazolylthio)propionic Acid>98.0%(T)500g

Methyl 3-(Benzylamino)propanoate>98.0%(GC)(T)5g

4-(bromomethyl)pyrrolidin-2-one, 95.0%, 5g

Bis(1H-1,2,3-benzotriazol-1-ylmethyl)(ethyl)amine, 250mg

3-BROMO-6-CHLORO-1-(PHENYLSULFONYL)-7-AZAINDOLE, 95.0%, 1g

2-Methylimidazo[1,2-b]pyridazin-6-amine, 95.0%, 250mg

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile, 95.0%, 100g